Dancing Through Diagnosis: Alnylam’s Givlaari Campaign Puts Rare Disease in the Spotlight
Alnylam Pharmaceuticals has launched a unique promotional campaign for Givlaari, its treatment for acute hepatic porphyria (AHP), that swaps the usual clinical narratives for something more artistic: dance. As reported…
Continue Reading
Dancing Through Diagnosis: Alnylam’s Givlaari Campaign Puts Rare Disease in the Spotlight
